Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now
Patent Armory v. Campus Protein — Intelligent Call Routing Patents | PatSnap
Explore in Eureka
Case ID1:25-cv-00290
FiledMar 2025
ClosedApr 2025
Patent Litigation

Patent Armory v. Campus Protein: Five Routing Patents, Dismissed in 21 Days

Patent Armory, Inc. filed suit in the District of Delaware asserting five patents spanning intelligent call routing, telephony control, and auction-based entity matching against supplement retailer Campus Protein, Inc. The case lasted just 21 days before Patent Armory voluntarily dismissed without prejudice under Rule 41(a)(1)(A)(i), leaving the door open for future action.

Resolution time
21days
21-day duration — well below the median district court patent case lifespan of 2–3 years
Patents asserted
5
US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1 — five intelligent routing and telephony patents asserted
Outcome
Voluntary dismissal
Dismissed without prejudice under Rule 41(a)(1)(A)(i); public record silent on with/without prejudice terms
Cost ruling
No Cost Order
No costs or fees recorded; defendant had not yet answered before dismissal
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

Five-Patent Routing Suit Against Supplement Retailer Ends Before Answer

On March 11, 2025, Patent Armory, Inc. filed Case No. 1:25-cv-00290 in the District of Delaware before Judge Maryellen Noreika, asserting infringement of five patents: US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1. The asserted patents collectively cover intelligent communication routing, telephony control with intelligent call routing, and method-and-system frameworks for matching entities in an auction context. The defendant, Campus Protein, Inc., is an online supplement and nutrition retailer.

On March 31, 2025 — just 20 days after filing — Patent Armory filed a notice of voluntary dismissal pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i), which permits a plaintiff to dismiss as of right before the defendant has served an answer or moved for summary judgment. Campus Protein had not yet responded to the complaint, making the procedural mechanism available without court order. The case was formally closed on April 1, 2025.

The 21-day lifespan is strikingly short and suggests the dismissal may have been driven by a pre-litigation settlement, licensing negotiation, or a reassessment of claim mapping against Campus Protein’s specific technology stack. Because the dismissal is without prejudice, Patent Armory retains the right to refile the same claims. The public record does not disclose any settlement terms, payment, or licensing agreement between the parties.

Case at a glance
Case no.1:25-cv-00290
CourtDelaware
JudgeMaryellen Noreika
FiledMarch 11, 2025
ClosedApril 1, 2025
Duration21 days
OutcomeVoluntary dismissal
Verdict causeInfringement Action
BasisVoluntary dismissal
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / Delaware District Court via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Voluntary dismissal in 21 days

21-day duration — well below the median district court patent case lifespan of 2–3 years

Case timeline: Complaint filed MAR 11 2025, MAR–APR — 21 days total Horizontal timeline showing the three key events in Patent Armory, Inc. v Campus Protein, Inc. from filing to resolution. Source: PACER, Delaware District Court. MAR 11 2025 Complaint filed Pre-trial proceedings APR 1 2025 Voluntary dismissal 21 DAYS TOTAL
Dismissal terms

Voluntarily dismissed: what the Rule 41 exit means for both parties

Legal mechanism

Rule 41(a)(1)(A)(i): plaintiff’s unilateral exit right

Federal Rule of Civil Procedure 41(a)(1)(A)(i) allows a plaintiff to dismiss an action without a court order at any point before the defendant serves an answer or a motion for summary judgment. Because Campus Protein had not yet answered, Patent Armory could file a one-page notice and exit instantly. No judicial approval was required, and no merits determination was made.

No court order needed
With or without prejudice?

The public record is silent on re-filing risk

The notice expressly states dismissal ‘without prejudice,’ meaning Patent Armory is legally free to refile the same five patents against Campus Protein at any time. A dismissal with prejudice would have permanently barred refiling. The distinction is commercially significant: without prejudice preserves all enforcement optionality, and there is no public record of any settlement, payment, or covenant not to sue.

Refiling remains possible
Defendant outcome

Campus Protein exits without a merits win — or a settlement on record

Campus Protein avoided the cost and disruption of full patent litigation, but the without-prejudice dismissal means it does not hold a judgment in its favour. If no private licensing agreement was reached, Campus Protein may face the same five patents in a future action. The absence of any defendant agent or counsel on the public docket suggests the matter may have been resolved informally before formal representation was entered.

No merits adjudication
Commercial implications

Intelligent routing patents remain live threats in e-commerce

Patent Armory’s portfolio spans foundational telephony and communication-routing technologies that can be asserted broadly across online retail and customer-service platforms. The rapid dismissal — before Campus Protein even retained visible counsel — is consistent with a licensing-resolution pattern commonly used by non-practising entities. Other e-commerce and direct-to-consumer brands operating similar routing or customer-contact infrastructure should treat this case as a signal to review exposure.

NPE enforcement pattern
Legal analysis based on PACER docket records for case 1:25-cv-00290 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffPatent Armory, Inc.CompanyPatent licensing entity — holder of US9456086B1, US10491748B1, US7269253B1, US7023979B1, US10237420B1Search in Eureka ↗
DefendantCampus Protein, Inc.CompanyCampus Protein, Inc. — online sports nutrition and supplement retailerSearch in Eureka ↗
Plaintiff counselAntranig N. GaribianAttorneyCounsel for Patent Armory, Inc.Search in Eureka ↗
Plaintiff law firmGaribian Law Offices, PCLaw FirmRepresenting Patent Armory, Inc.Search in Eureka ↗
Presiding judgeJudge Maryellen NoreikaJudgeDelaware District CourtSearch in Eureka ↗
Official verdict

Official order — verbatim text

“Pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i), Plaintiff Patent Armory Inc. hereby dismisses this action without prejudice. Defendant Campus Protein, Inc. has not yet answered the Complaint or moved for summary judgment. Date: March 31, 2025”
Source: PACER Docket, Case 1:25-cv-00290, Delaware District Court

The dismissal notice invokes Rule 41(a)(1)(A)(i) with precision, confirming that Campus Protein had not answered or moved for summary judgment — the two procedural prerequisites for a unilateral plaintiff exit. The phrase ‘without prejudice’ is explicit, preserving Patent Armory’s full right to refile. No merits finding was made on any of the five asserted patents, so validity and infringement questions remain entirely open. The speed of the filing-to-dismissal arc — 20 days — is the analytically significant data point, consistent with an out-of-court resolution rather than a substantive case evaluation.

PACER case 1:25-cv-00290 · Public docket record Explore in Eureka ↗
Patent at issue

US9456086B1 and four further patents — intelligent call routing and telephony control

Publication No.US9456086B1
Application No.US12/719827
Patent details
ProductIntelligent communication routing system and method
Cited in actionMarch 11, 2025

Publication No.US10491748B1
Application No.US15/797070
Patent details
ProductMethod and system for matching entities in an auction
Cited in actionMarch 11, 2025

Publication No.US7269253B1
Application No.US11/387305
Patent details
ProductTelephony control system with intelligent call routing
Cited in actionMarch 11, 2025

Publication No.US7023979B1
Application No.US10/385389
Patent details
ProductIntelligent communication routing — continuation family
Cited in actionMarch 11, 2025

Publication No.US10237420B1
Application No.US15/856729
Patent details
ProductIntelligent routing and entity matching — further continuation
Cited in actionMarch 11, 2025

The five asserted patents span two core technology clusters. The first cluster — US9456086B1, US10491748B1, US7269253B1, and US10237420B1 — covers intelligent communication routing systems and telephony control methods, encompassing how inbound and outbound calls or contacts are directed based on dynamic routing logic. The second cluster — US7023979B1 — addresses method-and-system frameworks for matching entities in an auction context, which may relate to routing callers to agents or service providers through a bid-based allocation mechanism. The application dates span from early-to-mid 2000s originals through mid-2010s continuations, suggesting a prosecution strategy designed to extend claim coverage into modern implementation environments.

From a strategic standpoint, communication-routing patents with broad method claims can map onto a wide range of customer-contact, IVR, and e-commerce recommendation systems used by online retailers. Campus Protein’s use of such infrastructure — common among direct-to-consumer brands managing inbound sales and support — is the likely nexus. Patent Armory’s ability to assert five patents simultaneously, spanning both routing logic and entity-matching methods, indicates a portfolio structured for maximum coverage against technology-dependent commercial operations. Competitors and adjacent companies in the supplement, nutrition, and online retail sectors should treat this portfolio as an active enforcement risk.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should your team run an FTO against US9456086B1 and the Patent Armory routing portfolio?

Any e-commerce, direct-to-consumer, or online retail business operating intelligent call routing, IVR systems, contact-centre software, or customer-matching platforms should consider an FTO assessment against this five-patent portfolio. The without-prejudice dismissal means Patent Armory can refile — against Campus Protein or any similarly situated company — at any time. If your product stack includes third-party or proprietary routing logic, agent-matching algorithms, or auction-based lead distribution, the asserted claims warrant review.

PatSnap Eureka’s FTO Search Agent can map the claim language of US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1 against your technology architecture and flag design-around opportunities or prior art that could challenge claim validity. Given that none of these patents has been subjected to public claim construction in this case, an independent analysis of claim scope is especially valuable before Patent Armory pursues its next target.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US9456086B1 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar Intelligent Routing and Telephony Patent Cases in Delaware District Court

Cases involving NPE assertion of intelligent call routing and telephony control patents in the District of Delaware follow recognisable patterns worth benchmarking against this dispute.

🔍
Access 40+ similar cases in PatSnap Eureka
Patent Armory, Inc. patent enforcement history, Delaware case history, Patent Armory, Inc.’s full IP portfolio, and comparable case analysis
Other Patent Armory suitsDelaware NPE routing casesRule 41 quick-dismiss patternTelephony patent verdicts
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the e-commerce and telephony IP landscape

A 21-day patent suit with five routing patents and no defendant counsel on record is a textbook NPE rapid-resolution pattern worth tracking.

Rule 41 exits before answer are a hallmark of NPE licensing campaigns

When a plaintiff dismisses under Rule 41(a)(1)(A)(i) within days of filing — and the defendant has no public counsel — it typically signals a quick licensing payment or pre-litigation resolution. Patent Armory’s five-patent portfolio and Delaware venue choice are consistent with a systematic assertion strategy rather than a one-off dispute.

Without-prejudice dismissal preserves full enforcement optionality

Campus Protein received no covenant not to sue on the public record. Any e-commerce company in the nutrition, supplement, or direct-to-consumer space using third-party call routing, IVR, or customer-matching systems should assess whether these five patents map to their own infrastructure before a similar notice arrives.

🔒
Full strategic analysis in PatSnap Eureka
Unlock full NPE enforcement analysis for intelligent routing patents litigated at the Delaware District Court level.
NPE campaign risk scoreSimilar Delaware routing suitsClaim scope analysis
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

Patent v Campus — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Track intelligent routing patent enforcement before the next filing lands

Patent Armory’s without-prejudice exit leaves five patents fully armed for redeployment. Use PatSnap Eureka to monitor this portfolio, map claim exposure across your routing infrastructure, and build an FTO position before a new complaint arrives.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Related Litigation Cases

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.